Title : AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway.

Pub. Date : 2020 Sep

PMID : 32678482






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bioinformation analyses and mechanistic studies demonstrated that AKR1C2 activated the PI3K/AKT signalling pathway, furthermore, the inhibitor of PI3K or the selective inhibitor of AKR1C2 enzyme activity could reverse the aggressiveness and showed synergistic antitumour effect when combined with cisplatin, both in vitro and in vivo. Cisplatin AKT serine/threonine kinase 1 Homo sapiens